PubRank

A C Williams

Author PubWeight™ 177.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992 3.30
2 Problems in assessing contents of metered dose inhalers. BMJ 1993 3.07
3 Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1979 2.61
4 Starch-Ampicillin Agar for the Quantitative Detection of Aeromonas hydrophila. Appl Environ Microbiol 1985 1.72
5 Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl 1996 1.72
6 CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry 1980 1.59
7 Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet 1987 1.48
8 Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett 1990 1.47
9 Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 1999 1.45
10 Influence of surgeon's experience on speech outcome in cleft lip and palate. Lancet 1999 1.44
11 Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008 1.43
12 Migraine after bone-marrow transplantation. Lancet 1989 1.43
13 Updated guidelines for the management of Parkinson's disease. Hosp Med 2001 1.41
14 The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol 1970 1.35
15 Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 1991 1.32
16 Submandibular duct sialolith of unusual size and shape. J Oral Surg 1975 1.31
17 Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 2003 1.30
18 A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 1999 1.25
19 Sexual difficulties of chronic pain patients. Clin J Pain 2001 1.25
20 Long-term treatment of parkinsonism with bromocriptine. Lancet 1978 1.24
21 Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J 2001 1.21
22 Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997 1.19
23 Encephalopathy associated with ifosphamide/mesna therapy. Lancet 1985 1.17
24 Xenobiotic metabolism in motor neuron disease. Lancet 1988 1.16
25 Xenobiotic metabolism in Parkinson's disease. Neurology 1989 1.16
26 Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000 1.15
27 Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 4: outcome comparisons, training, and conclusions. Cleft Palate Craniofac J 2001 1.12
28 Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol 1990 1.10
29 The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain 1994 1.08
30 Spinal cord stimulation and the relief of chronic pain. J Neurol Neurosurg Psychiatry 1987 1.06
31 Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 1: background and methodology. Cleft Palate Craniofac J 2001 1.03
32 Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry 1988 1.02
33 Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer 1970 1.01
34 Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science 1979 1.01
35 Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 1999 1.01
36 Smoking habits of Florida physicians revisited. JFMA 1972 1.01
37 The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 2005 1.00
38 Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry 1987 1.00
39 Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection. Soc Sci Med 1997 0.99
40 Motoneurone disease as manifestation of pesticide toxicity. Lancet 1987 0.99
41 Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet 1996 0.98
42 Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology 1990 0.98
43 Derepression of synthesis of the aminoacyl-transfer ribonucleic acid synthetases for the branched-chain amino acids of Escherichia coli. J Bacteriol 1974 0.98
44 Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 2001 0.98
45 Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer 1994 0.97
46 Bax inhibitor 1 in apoptosis and disease. Oncogene 2011 0.97
47 Are the Peer Assessment Rating Index and the Index of Treatment Complexity, Outcome, and Need suitable measures for orthognathic outcomes? Eur J Orthod 2006 0.96
48 Characterization of the Aeromonas hydrophila group isolated from retail foods of animal origin. J Clin Microbiol 1989 0.95
49 Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review). Anticancer Res 1990 0.95
50 The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene 2010 0.95
51 Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis 2005 0.94
52 S-methylation in motorneuron disease and Parkinson's disease. Lancet 1989 0.94
53 Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis 2003 0.94
54 Plagiarism, retraction and the future. Hum Reprod 2011 0.94
55 Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol 1995 0.93
56 Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods. Pain 1994 0.92
57 Hyponatraemia as a cause of reversible ataxia. Br Med J (Clin Res Ed) 1986 0.92
58 Deterioration of Wilson's disease following the start of penicillamine therapy. Arch Neurol 1989 0.92
59 Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci 1996 0.92
60 Toxicity of sulphur-containing compounds to neuronal cell lines. J Neurol Sci 1995 0.91
61 Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer 1996 0.91
62 Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry 2003 0.91
63 Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet 1987 0.90
64 Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Hosp Med 1998 0.90
65 Prospects in NSAID-derived chemoprevention of colorectal cancer. Biochem Soc Trans 2005 0.90
66 Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol 2001 0.90
67 Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem Soc Trans 2005 0.89
68 Bonding of metal attachments to teeth for treatment of mandibular fractures. J Oral Surg 1974 0.89
69 Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004 0.88
70 An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995 0.88
71 IGFBP-3 and apoptosis--a license to kill? Apoptosis 2001 0.88
72 The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells. Cell Death Dis 2012 0.87
73 The neuropathy of the critically ill. Br Med J (Clin Res Ed) 1986 0.87
74 Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 2000 0.87
75 In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines. Neurotoxicology 1998 0.87
76 The chewing stick: its uses and relationship to oral health. J Prev Dent 1978 0.86
77 Panfacial cellulitis with contralateral orbital cellulitis and blindness after tooth extraction. J Oral Surg 1977 0.86
78 Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. Int J Pharm 2010 0.86
79 Self-attempted endodontics--a case report. ASDC J Dent Child 1969 0.86
80 Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain 2001 0.86
81 Acute epidural abscess. Am J Emerg Med 1987 0.86
82 Bromocriptine inhibits norepinephrine release. Clin Pharmacol Ther 1979 0.86
83 Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J Pharm Pharmacol 1998 0.85
84 Lipid peroxidation and Parkinson's disease. Lancet 1986 0.85
85 The process of orthognathic care in an NHS region. Ann R Coll Surg Engl 2009 0.85
86 Mammographic examinations (4030): ten-year clinical experience in a community medical center. Ann Surg 1973 0.85
87 Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells. Br J Cancer 2001 0.85
88 Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release 1998 0.85
89 Nomalike lesion in a patient with chronic lymphocytic leukemia. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol 1976 0.84
90 BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis. Oncogene 2011 0.84
91 Cytochrome P450 1B1 mRNA in the human central nervous system. Mol Pathol 1998 0.84
92 Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm 2001 0.84
93 Chromosomal localisation of genes coding for human and mouse liver cytosolic cysteine dioxygenase. Ann Hum Genet 1996 0.84
94 Combined phenyl silane and immunoaffinity column cleanup with liquid chromatography for determination of ochratoxin A in roasted coffee: collaborative study. J AOAC Int 2001 0.84
95 Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 1997 0.84
96 Renal localisation of rat cysteine dioxygenase. Nephron 2001 0.83
97 Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. J Pharm Sci 1998 0.83
98 Familial paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1984 0.83
99 Human cysteine dioxygenase type I: primary structure derived from base sequencing of cDNA. Biochim Biophys Acta 1994 0.83
100 Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular attack. Kidney Int 1999 0.83
101 Parkinson's disease: clinical and therapeutic aspects. Curr Opin Neurol Neurosurg 1992 0.83
102 Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica 1990 0.83
103 Research in primary dental care. Part 2: Developing a research question. Br Dent J 2004 0.82
104 Kinetic analysis by stopped-flow radiationless energy transfer studies: effect of anions on the activity of carboxypeptidase A. Biochemistry 1986 0.82
105 Ankylosis of the coronoid process to the zygomatic arch and maxilla: report of case. J Oral Surg 1968 0.82
106 Intracranial gumma presenting as a cerebral tumour. J R Soc Med 1988 0.82
107 Further studies in xenobiotic metabolism and Parkinson's disease. Adv Neurol 2001 0.82
108 The role of the retinoblastoma protein (Rb) in the nuclear localization of BAG-1: implications for colorectal tumour cell survival. Biochem Soc Trans 2005 0.81
109 Modulation of p53 expression in cultured colonic adenoma cell lines by the naturally occurring lumenal factors butyrate and deoxycholate. Int J Cancer 1997 0.81
110 Liquid chromatographic method with immunoaffinity column cleanup for determination of ochratoxin A in barley: collaborative study. J AOAC Int 2000 0.81
111 Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease. Biochem Soc Trans 1993 0.81
112 Sucrose reduces the efficiency of protein denaturation by a chaotropic agent. Biochim Biophys Acta 1995 0.81
113 Development of an in vitro model for cysteine dioxygenase expression in the brain. Cell Biol Toxicol 2000 0.81
114 The molecular biology of xenobiotic enzymes and the predisposition to idiopathic Parkinson's disease. Adv Neurol 1996 0.81
115 Hepatic localisation of rat cysteine dioxygenase. J Hepatol 1998 0.81
116 An investigation into the practice of tongue piercing in the South West of England. Br Dent J 2006 0.80
117 Characterization of frozen glucose solutions. Pharm Dev Technol 1997 0.80
118 Attrition from a pain management programme. Br J Clin Psychol 1995 0.80
119 Platelet counts in healthy adult Sierra Leoneans. West Afr J Med 1997 0.80
120 Expression of cysteine dioxygenase (EC 1.13.11.20) and sulfite oxidase in the human lung: a potential role for sulfate production in the protection from airborne xenobiotica. Mol Pathol 2003 0.80
121 Cysteine dioxygenase: regional localisation of protein and mRNA in rat brain. J Neurosci Res 2001 0.80
122 Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 2009 0.80
123 Thermally induced molecular disorder in human stratum corneum lipids compared with a model phospholipid system; FT-Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc 1998 0.80
124 Reactive oxygen species in human sperm suspensions: production by leukocytes and the generation of NADPH to protect sperm against their effects. Int J Androl 1997 0.80
125 A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol. Biochim Biophys Acta 1998 0.80
126 Are different events involved in the development of sporadic versus hereditary tumours? The possible importance of the microenvironment in hereditary cancer. Br J Cancer 1990 0.80
127 Human brain cytochrome P450 1B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz(a)anthracene in astrocytoma cell line (MOG-G-CCM). Neurosci Lett 2000 0.80
128 Dentoalveolar relations in children born with a unilateral cleft lip and palate (UCLP) in Western Australia. Cleft Palate Craniofac J 2000 0.80
129 Ergot derivatives for Parkinsonism. Med J Aust 1978 0.79
130 Extrapyramidal disturbances caused by inappropriate prescribing. Br Med J (Clin Res Ed) 1987 0.79
131 BAG-1 enhances cell-cell adhesion, reduces proliferation and induces chaperone-independent suppression of hepatocyte growth factor-induced epidermal keratinocyte migration. Exp Cell Res 2010 0.79
132 Xenobiotic metabolism in Alzheimer's disease. Neurology 1990 0.79
133 Autoimmunity in stiff man syndrome. Lancet 1988 0.79
134 Drug interaction and location in liposomes: correlation with polar surface areas. Int J Pharm 2005 0.79
135 BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells. Oncogene 2012 0.78
136 Effect of melting point of chiral terpenes on human stratum corneum uptake. Int J Pharm 2001 0.78
137 Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. Brain 2002 0.78
138 Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci 1998 0.78
139 Monoamine oxidase B and Parkinson's disease. Lancet 1990 0.78
140 Hyperproinsulinaemia in patients with myotonic dystrophy. Diabetologia 1992 0.78
141 Successful treatment of mucocutaneous mucormycosis after dental extractions in a patient with uncontrolled diabetes. J Oral Surg 1975 0.78
142 Promotability and tissue specificity of hereditary cancer genes: do hereditary cancer patients have a reduced requirement for tumor promotion because all their somatic cells are heterozygous at the predisposing locus? Mol Carcinog 1992 0.78
143 The eye movement disorders of progressive supranuclear palsy. Ophthalmology 1979 0.78
144 Relationship between the secretion of cysteine proteinases and their inhibitors and malignant potential. Biochem Soc Trans 1991 0.78
145 A qualitative study to develop a tool to examine patients' perceptions of NHS orthodontic treatment. J Orthod 2006 0.78
146 Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy. Metabolism 1990 0.78
147 The development of a patient-centered measure of the process and outcome of combined orthodontic and orthognathic treatment. J Orthod 2004 0.78
148 Research in primary dental care. Part 5: devising a proposal, obtaining funding and ethical considerations. Br Dent J 2004 0.78
149 Suppurative osteomyelitis of the mandible secondary to fracture. Report of a case. Oral Surg Oral Med Oral Pathol 1974 0.78
150 Determination of the GSTM1 gene deletion frequency in Parkinson's disease by allele specific PCR. Parkinsonism Relat Disord 1996 0.78
151 Permeation of bioactive constituents from Arnica montana preparations through human skin in-vitro. J Pharm Pharmacol 2006 0.78
152 A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma. Int J Cancer 1992 0.77
153 Pesticide toxicity and motor neuron disease. J Neurol Neurosurg Psychiatry 1990 0.77
154 Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology 1980 0.77
155 Cysteine dioxygenase: regional expression of activity in rat brain. Neurosci Lett 1998 0.77
156 Iron and akathisia. Br Med J (Clin Res Ed) 1986 0.77
157 β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin? Br J Cancer 2012 0.77
158 Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate in situ FT-Raman spectroscopy. Pharm Res 1998 0.77
159 Preliminary study of chronic pain patients' concerns about cannabinoids as analgesics. Clin J Pain 2001 0.77
160 Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status. J Clin Endocrinol Metab 1995 0.77
161 Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology 1998 0.76
162 Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms. Br J Pharmacol 2013 0.76
163 Inhibition of human benzylamine oxidase (BzAO) by analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Lett 1990 0.76
164 Topical 5-FU--a new approach to skin cancer. Ann Surg 1971 0.76
165 Adenoameloblastoma (odontogenic adenomatoid tumor): report of case. J Oral Surg 1972 0.76
166 Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells. Braz J Med Biol Res 2004 0.76
167 Pathways of cysteine metabolism in MND/ALS. J Neurol Sci 1994 0.76
168 Parkinsonism and Down syndrome. Lancet 1989 0.76
169 Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy. Metabolism 1991 0.76
170 Penciclovir solubility in Eudragit films: a comparison of X-ray, thermal, microscopic and release rate techniques. J Pharm Biomed Anal 2004 0.76
171 Human cysteine dioxygenase type I (CDO-I; EC 1.13.11.20): 5' flanking region and intron-exon structure of the gene. Mol Pathol 1997 0.76
172 Abnormal regulation of carbohydrate metabolism in motor neurone disease. Diabetes Res 1991 0.75
173 Facial flushing and localized Castleman's disease: an extension of the POEMS syndrome phenotype. J Intern Med 2003 0.75
174 Cisplatin neuropathy with Lhermitte's sign. J Neurol Neurosurg Psychiatry 1986 0.75
175 Assessing inhaler fullness. Br J Gen Pract 1994 0.75
176 Hot-bath epilepsy. Postgrad Med J 1987 0.75
177 Complete structural characterisation of the human aryl hydrocarbon receptor gene. Clin Mol Pathol 1996 0.75
178 Hypomagnesaemia causing myopathy and hypocalcaemia in an alcoholic. Postgrad Med J 1987 0.75
179 The effects of cognitive-behavioural therapy in chronic pain. Pain 1997 0.75
180 Psychological rehabilitation after myocardial infarction. BMJ 1997 0.75
181 Rehabilitation for chronic low back pain. Review was of little help in selecting treatment. BMJ 2001 0.75
182 Cystine, sulfate, and ALS. Neurology 1991 0.75
183 Palatal myoclonus influenced by head posture. J Neurol Neurosurg Psychiatry 1987 0.75
184 Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants. J Neurol Neurosurg Psychiatry 1987 0.75
185 Erythrocyte thiolmethyltransferase. Neurology 1996 0.75
186 Long-term benzodiazepine use and pain. J R Soc Med 1991 0.75
187 Ferritin in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1990 0.75
188 Penicillamine induced myasthenia reactivated by gold. Br Med J (Clin Res Ed) 1984 0.75
189 Meta-analysis of antidepressant-induced analgesia in chronic pain: comment. Pain 1993 0.75
190 A compulsive movement disorder with cavitation of caudate nucleus. J Neurol Neurosurg Psychiatry 1988 0.75
191 Intra-operative blood glucose and serum insulin concentrations in the surgical management of insulinoma. Postgrad Med J 1990 0.75
192 Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. J Pharm Pharmacol 1996 0.75
193 Platelet MAO activities and MAO-B protein concentrations in Parkinson's disease and controls. Prog Brain Res 1995 0.75
194 Surgical approach to an oronasal fistula of 40 years' duration. Oral Surg Oral Med Oral Pathol 1970 0.75
195 Alterations in concentrations of cyclic guanosine 3',5'-monophosphate in guinea pig urine during the development of a transplantable leukaemia. Cancer Lett 1985 0.75
196 Ochratoxin A in wheat: certification of two reference materials. Food Addit Contam 1997 0.75
197 Monoamine oxidase substrates in Parkinson's disease. Biochem Pharmacol 1990 0.75
198 Assisted reproductive technologies in europe encompass diverse and complex ethical viewpoints: issues to be considered in reporting research in human reproduction. Ann N Y Acad Sci 2004 0.75
199 Toxicity of cysteine and cysteine sulphinic acid to human neuronal cell-lines. J Neurol Sci 1997 0.75
200 Cell and molecular biology of gastrointestinal tract cancer. Curr Opin Oncol 1992 0.75
201 Access to dental services in Scotland: an analysis of dentist-population ratios. Br Dent J 2007 0.75
202 An intercomparison of methods for the determination of ochratoxin A in pig kidney. Food Addit Contam 1997 0.75
203 A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease. Drug Metabol Drug Interact 2001 0.75
204 Influence of food intake during late gestation on serum lipids of sows and their progeny. Biol Neonate 1987 0.75
205 Insulin and proinsulin-like molecules in motor neurone disease. Ann Clin Biochem 1993 0.75
206 Who should we trust? Hum Reprod 2017 0.75
207 Platelet monoamine oxidase-B activity in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1989 0.75
208 Therapeutic progress--review XX. Drug treatment of Parkinson's disease. J Clin Hosp Pharm 1986 0.75
209 Platelet sulphotransferase activity, plasma sulphate levels and sulphation capacity in patients with migraine and tension headache. Cephalalgia 1997 0.75
210 Sorbitol is a possible risk factor for diarrhea in young children. J Am Diet Assoc 1997 0.75
211 BAG-1L promotes keratinocyte differentiation in organotypic culture models and changes in relative BAG-1 isoform abundance may lead to defective stratification. Exp Cell Res 2011 0.75
212 Inhibition of dopamine uptake into PC-12 cells by analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Parkinsonism Relat Disord 1996 0.75
213 Practical aspects to undertaking research in the primary care setting: experience from two studies. J Orthod 2005 0.75
214 D-penicillamine metabolism in neurodegenerative diseases: an in vivo/in vitro sulphydryl methylation study. Xenobiotica 1994 0.75
215 Nasopalatine cyst of unusual size: report of case. J Oral Surg 1973 0.75
216 Branchial cyst. Report of a case. Oral Surg Oral Med Oral Pathol 1969 0.75
217 Postextraction bleeding in a patient with an acquired circulating anticoagulant against factor V. Oral Surg Oral Med Oral Pathol 1971 0.75
218 Tardive dystonia: which way do schizophrenics twist? Lancet 1987 0.75
219 Ameloblastoma of the mandible: report of case. J Oral Surg 1969 0.75
220 Interleukin-2 induced changes in mononuclear cell surface charge. Adv Exp Med Biol 1988 0.75
221 Dentigerous cyst with ameloblastomatous proliferation: report of a case. J Oral Surg 1971 0.75
222 Reticulum-cell sarcoma of the mandible. Oral Surg Oral Med Oral Pathol 1969 0.75
223 Iron, akathisia, and antipsychotic drugs. Lancet 1987 0.75
224 Traumatic intrusion of a maxillary central incisor. J Am Dent Assoc 1969 0.75
225 Adoptive transfer of immunity by spleen cells from LSA-lymphoma mice cured by BCNU. Leuk Res 1984 0.75
226 Supraorbital emphysema: report of case. J Oral Surg 1972 0.75
227 The effects of a cognitive-behavioral pain management programme on the quality of work and employment status of severely impaired chronic pain patients. Disabil Rehabil 1994 0.75
228 Malignant hyperpyrexia? Anaesthesia 1982 0.75
229 Perspective on skin cancer. J Surg Oncol 1971 0.75
230 Increased CSF IgM in multiple sclerosis. Neurology 1978 0.75
231 Interaction of motor neurone disease plasma with glucose transport. Funct Neurol 1993 0.75
232 Activation of bovine plasma benzylamine oxidase (BzAO) by 1-methyl-4-(2-methylphenyl)-1,2,3,6-tetrahydropyridine. Toxicol Lett 1992 0.75
233 A bullet lodged in the glenoid fossa: report of case. J Oral Surg 1968 0.75
234 Development and validation of an instrument for characterizing food-related behavior. J Am Diet Assoc 1985 0.75
235 Interaction of salicylic acid with verrucae assessed by FT-Raman spectroscopy. J Drug Target 1998 0.75
236 A simple surgical treatment of intraoral fibrous scars utilizing a skin graft. Report of a case. Oral Surg Oral Med Oral Pathol 1969 0.75
237 Thrombocytopenia. Secondary to antituberculous therapy. J N J Dent Assoc 1974 0.75
238 Pericarditis secondary to tooth extraction in a patient with myeloid metaplasia: report of case. J Oral Surg 1973 0.75
239 The development of a toothbrushing programme at a school for children with moderate and severe learning difficulties. Community Dent Health 1990 0.75
240 Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 1992 0.75
241 Copper chelation and the neuro-ophthalmic toxicity of desferrioxamine. Lancet 1986 0.75
242 Thrombotic thrombocytopenic purpura: report of case. J Oral Surg 1977 0.75
243 Research in primary dental care. Part 7: writing up your research. Br Dent J 2004 0.75
244 Using skinfold calipers while teaching body fatness-related concepts: cognitive and affective outcomes. J Sci Med Sport 2003 0.75
245 Healthcare services for low-incidence anomalies. Med J Aust 2000 0.75
246 Mandibular deformity associated with nonunion treated by vertical osteotomy: report of case. J Oral Surg 1971 0.75
247 Fatal massive edema of the head and neck secondary to scalp laceration: report of case. J Oral Surg 1977 0.75
248 Localized osteomyelitis of the maxilla in a patient with lymphosarcoma. A case for correct diagnosis. N Y State Dent J 1976 0.75
249 Meningitis as a result of a postextraction infection: report of case. J Oral Surg 1972 0.75
250 Subacute polyradiculopathy with optic and auditory nerve involvement. Arch Neurol 1987 0.75
251 Chronic low back pain: predictions of pain and relationship to anxiety and avoidance. Behav Res Ther 1997 0.75
252 Production in nature of compound resembling methylphenyltetrahydropyridine, a possible cause of Parkinson's disease. Lancet 1985 0.75
253 Photocephalography for evaluation of tissue relations in mandibular surgery. J Oral Surg 1977 0.75
254 'Castles of health'. QJM 1994 0.75
255 The HhaI polymorphism in the CYP2D6 gene is not associated with Parkinson's disease in a Caucasian population. Eur J Neurol 1995 0.75
256 The role of entacapone in the management of Parkinson's disease. Hosp Med 2000 0.75
257 Radiological case of the month. Patent urachal duct. Am J Dis Child 1992 0.75
258 Dimethylnitrosamine in souse and similar jellied cured-meat products. Food Cosmet Toxicol 1975 0.75
259 MAO-B and Parkinson's disease. Mov Disord 1990 0.75
260 Parahemophilia. A case diagnosed after excessive postextraction bleeding. Oral Surg Oral Med Oral Pathol 1971 0.75
261 Management of a feeding problem in an infant with cleft palate. J Am Dent Assoc 1968 0.75
262 Management of the narcotic-addicted surgical patient: concepts of medical and surgical care. J Oral Surg 1970 0.75
263 Patients' experiences after undergoing orthognathic surgery at NHS hospitals in the south west of England. Br J Oral Maxillofac Surg 2004 0.75
264 The location and occurrence of mandibular fractures. An analysis of 202 cases. Oral Surg Oral Med Oral Pathol 1969 0.75
265 Neoplastic angioendotheliomatosis: a treatable "vascular dementia" occurring in an immunosuppressed transplant patient. Clin Neuropathol 1993 0.75
266 Protein conformational stability in the hydrofluoroalkane propellants tetrafluoroethane and heptafluoropropane analysed by Fourier transform Raman spectroscopy. Int J Pharm 1999 0.75
267 Synthesis and nuclear magnetic resonance spectroscopic, mass spectroscopic, and plasma amine oxidase inhibitory properties of analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 1988 0.75
268 Cold agglutinins. Cause for concern? Anaesthesia 1980 0.75
269 Research in primary dental care. Part 1: Setting the scene. Br Dent J 2004 0.75
270 Gigantic ameloblastoma of the mandible: report of case. J Oral Surg 1974 0.75